Trial Profile
Single centre, retrospective, trial of eslicarbazepine acetate to assess mono-therapy experience
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Feb 2016
Price :
$35
*
At a glance
- Drugs Eslicarbazepine acetate (Primary)
- Indications Partial epilepsies
- Focus Adverse reactions; Therapeutic Use
- 23 Feb 2016 New trial record